John Young CFA

Stock Analyst at Canaccord Genuity

(1.26)
# 3,712
Out of 5,051 analysts
102
Total ratings
43.8%
Success rate
-1.2%
Average return

Stocks Rated by John Young CFA

AngioDynamics
Oct 9, 2026
Reiterated: Buy
Price Target: $20
Current: $11.40
Upside: +75.44%
STAAR Surgical Company
Sep 24, 2026
Reiterated: Buy
Price Target: $32
Current: $22.01
Upside: +45.39%
Pulmonx
Aug 11, 2026
Reiterated: Buy
Price Target: $5
Current: $1.80
Upside: +177.78%
Merit Medical Systems
Aug 11, 2026
Reiterated: Buy
Price Target: $94
Current: $89.75
Upside: +4.74%